Variables | Mean ± SD Placebo(n = 28) | Mean ± SD Ellagic acid (n = 29) | P1 | |
---|---|---|---|---|
FSH (ng/ml) | Baseline | 6 ± 1.85 | 6.02 ± 1.91 | 0.57 |
End | 6.01 ± 1.73 | 6.07 ± 1.9 | 0.601 | |
P2 | 0.55 | 0.49 | Â | |
Mean Changes | 0.01 ± 0.12 | 0.05 ± 0.01 | 0.68 | |
LH (ng/ml) | Baseline | 10.51 ± 2.19 | 10.84 ± 2.1 | 0.601 |
End | 10.83 ± 2.02 | 9.73 ± 2.4 | 0.073 | |
P2 | 0.58 | 0.076 | Â | |
Mean Changes | 0.32 ± 0.17 | -1.11 ± 0.3 | 0.079 | |
Total Testosterone (ng/ml) | Baseline | 0.6 ± 0.031 | 0.58 ± 0.023 | 0.61 |
End | 0.59 ± 0.04 | 0.38 ± 0.017 | 0.038 | |
P2 | 0.521 | 0.04 | Â | |
Mean Changes | -0.01 ± 0.09 | -0.2 ± 0.06 | 0.042 | |
Prolactin (ng/ml) | Baseline | 19.08 ± 4.5 | 19.91 ± 4.07 | 0.73 |
End | 19 ± 4.11 | 12.3 ± 2.39 | 0.025 | |
P2 | 0.671 | 0.036 | Â | |
Mean Changes | 0.32 ± 0.39 | -7.61 ± 1.68 | 0.033 | |
AMH (ng/ml) | Baseline | 12.02 ± 3.71 | 11.27 ± 3.07 | 0.43 |
End | 11.9 ± 3.1 | 7.2 ± 1.01 | 0.036 | |
P2 | 0.318 | 0.04 | Â | |
Mean Changes | -0.12 ± 0.61 | -4.07 ± 2.06 | 0.045 |